Stock listing

300347 Stock Price, News, Filings & Events — Hangzhou Tigermed Consulting Co., Ltd. Class A

Selected listing: 300347 · SZSE · CNY · CN

This page tracks Hangzhou Tigermed Consulting Co., Ltd. Class A's 300347:SZSE listing on SZSE in CNY for CN, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 300347:SZSE. 300347:SZSE is the stock-level entry point for investors researching Hangzhou Tigermed Consulting Co., Ltd. Class A, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Hangzhou Tigermed Consulting Co., Ltd. Class A is a public company listed on the Chinese stock market under the ticker 300347. The company has a market capitalization of approximately 5.94 billion USD. Tigermed specializes in providing comprehensive clinical research services and solutions to the pharmaceutical and biotechnology industries.

300347:SZSECNYCNUpdated September 11, 2026

Ticker: 300347:SZSE
Asset type: Stock
Market cap: $6.07B
Sector: Health Technology
Industry: Biotechnology
Exchange: SZSE
Currency: CNY

Hangzhou Tigermed Consulting Co., Ltd. Class A 300347:SZSE stock context

Latest news from Hangzhou Tigermed Consulting Co., Ltd. Class A

Hangzhou Tigermed Consulting : Tigermed and Veeda Lifesciences Forge Strategic Clinical Research for Global Drug Development

September 3, 2026

Tigermed Announces 2025 Annual Results

March 30, 2026

Tigermed Selected as "2025 Forbes China Go-International Flagship Brands" Top 30

November 6, 2025

Tigermed Receives MSCI ESG AAA Rating

August 18, 2025

Tigermed Completes Acquisition of Japanese CRO Micron

July 29, 2025

All Hangzhou Tigermed Consulting Co., Ltd. Class A news →

Research Hangzhou Tigermed Consulting Co., Ltd. Class A

Hangzhou Tigermed Consulting Co., Ltd. Class A investor report

Review AI stock analysis and investor report context for 300347:SZSE.

Hangzhou Tigermed Consulting Co., Ltd. Class A company profile

View the public company page for Hangzhou Tigermed Consulting Co., Ltd. Class A on 6ix.

Hangzhou Tigermed Consulting Co., Ltd. Class A news

Read company news and market updates connected to Hangzhou Tigermed Consulting Co., Ltd. Class A.

Hangzhou Tigermed Consulting Co., Ltd. Class A investor events

Find investor webinars, events, and replay context for Hangzhou Tigermed Consulting Co., Ltd. Class A.